ロード中...
Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer
As a master regulator of chromatin function, the lysine methyltransferase EZH2 orchestrates transcriptional silencing of developmental gene networks. Overexpression of EZH2 is commonly observed in human epithelial cancers, such as non-small cell lung carcinoma (NSCLC), yet definitive demonstration o...
保存先:
| 出版年: | Cancer Discov |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010480/ https://ncbi.nlm.nih.gov/pubmed/27312177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-0164 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|